TABLE 2.
Frequency with which surgical margins were evaluated prior to enrollment in ACOSOG Z5031 as determined by critical review of the pathology reports (n = 79)
| Result | No. of patients (%) |
|||
|---|---|---|---|---|
| SMA | CBD | Panc | AJCCa,b | |
| Evaluated, n (%) | 37 (47) | 74 (94) | 79 (100) | 36 (46) |
| Positive, n (%) | 14 (38) | 2 (3) | 12 (15) | 16 (44) |
| Negative, n (%) | 23 (62) | 72 (97) | 67 (85) | 20 (56) |
SMA superior mesenteric artery margin, CBD common bile duct margin, Panc pancreatic neck margin, AJCC American Joint Committee on Cancer
One pathology report was incomplete at the time of review
a
Cases in which all three margins recommended by the AJCC (sixth edition)—SMA, CBD, and Panc—were evaluated11
b
Positive indicates at least one margin of the three AJCC margins was positive; negative indicates all three margins were negative